3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Pain, Postoperative
31
Breast Neoplasms
24
Agnosia
11
Pain
10
Lung Neoplasms
10
Leiomyoma
7
Pancreatic Neoplasms
5
Neoplasms
5
Prostatic Neoplasms
4
Rectal Neoplasms
3
Neuroma
3
Neuralgia
3
Hot Flashes
3
Colorectal Neoplasms
3
Colonic Neoplasms
3
Thyroid Nodule
2
Thyroid Neoplasms
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Lymphedema
2
Liver Neoplasms
2
Kidney Neoplasms
2
Ileus
2
Hyperparathyroidism
2
Goiter
2
Digestive System Diseases
2
Chronic Pain
2
Breast Cancer Female
2
Brain Neoplasms
2
Adenomyosis
2
Abdominal Cancer
2
Interventions
Certolizumab Pegol
5
Infliximab
4
Adalimumab
3
Nivolumab
2
MEDI2070
2
vedolizumab
1
secukinumab
1
golimumab
1
cabozantinib
1
Vitamin E
1
Vaccines
1
Ustekinumab
1
Sutures
1
Surgical Instruments
1
Specimen Handling
1
Soybean Oil
1
Saline Solution
1
Ringer's Lactate
1
Pneumococcal Vaccines
1
Platinum Compounds
1
Photoplethysmography
1
Papillomavirus Vaccines
1
Methoxsalen
1
Medical Marijuana
1
Lysine Acetyltransferase 5
1
Iron-Dextran Complex
1
Ipilimumab
1
Indigo Carmine
1
Hydroxyethyl Starch Derivatives
1
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Crohn Disease
×
Bupivacaine
×
Clear all
NCT03723447
2021-02-17
TINGLE
Cedars-Sinai Medical Center
Phase 4
Completed
102 enrolled
9 charts